Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect
Open Access
- 1 June 2013
- journal article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 11 (4), 414-429
- https://doi.org/10.2174/1570159X11311040005
Abstract
Abstract: Alzheimer’s disease (AD) is the most common neurodegenerative disorder to date, with no curative or preventive therapy. Histopathological hallmarks of AD include deposition of β-amyloid plaques and formation of neurofibrillary tangles. Extent studies on pathology of the disease have made important discoveries regarding mechanism of disease and potential therapeutic targets. Many cellular changes including oxidative stress, disruption of Ca2+ homeostasis, inflammation, metabolic disturbances, and accumulation of unfolded/misfolded proteins can lead to programmed cell death in AD. Despite intensive research, only five approved drugs are available for the management of AD. Hence, there is a need to look at alternative therapies. Use of natural products and culinary herbs in medicine has gained popularity in recent years. Several natural substances with neuroprotective effects have been widely studied. Most of these compounds have remarkable antioxidant properties and act mainly by scavenging free radical species. Some of them increase cell survival and improve cognition by directly affecting amyloidogenesis and programmed cell death pathways. Further studies on these natural products and their mechanism of action, parallel with the use of novel pharmaceutical drug design and delivery techniques, enable us to offer an addition to conventional medicine. This review discussed some natural products with potential neuroprotective properties against Aβ with respect to their mechanism of action.Keywords
This publication has 105 references indexed in Scilit:
- Wnt signaling in development and diseaseNeurobiology of Disease, 2010
- MemantineCNS Drugs, 2009
- Amyloid-Beta Associated with Chitosan Nano-Carrier has Favorable Immunogenicity and Permeates the BBBAAPS PharmSciTech, 2009
- Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's diseaseThe Journal of Nutritional Biochemistry, 2009
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid BerberineJournal of Clinical Endocrinology & Metabolism, 2008
- Efficacy of berberine in patients with type 2 diabetes mellitusMetabolism, 2008
- CURCUMIN: THE INDIAN SOLID GOLDAdvances in experimental medicine and biology, 2006
- The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta AmyloidNeurochemical Research, 2006
- ER Stress Regulation of ATF6 Localization by Dissociation of BiP/GRP78 Binding and Unmasking of Golgi Localization SignalsDevelopmental Cell, 2002
- Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid β peptide and interleukin-1βNeuroscience Letters, 2002